Skip to main content
Erschienen in: Current Treatment Options in Gastroenterology 2/2024

27.03.2024

FLIP in Clinical Practice: When Is It Helpful?

verfasst von: Elena C. Pezzino, MD, Daniel R. Arndorfer, MD, Dustin A. Carlson, MD, MSCI

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Functional lumen imaging probe (FLIP) Panometry is as an important tool in the diagnosis and management of esophageal disorders.

Recent Findings

Using high-resolution impedance planimetry, FLIP assesses esophagogastric junction (EGJ) and esophageal body distensibility as well as the contractile response to distension (secondary peristalsis) at the time of sedated endoscopy. These features can be incorporated to classify esophageal motility, which often parallels high-resolution manometry (HRM) and the Chicago Classification (CCv4.0). The role of FLIP Panometry has been evaluated in multiple clinical scenarios, such as clarifying inconclusive HRM, excluding primary esophageal motility disorders, and guiding management for esophageal diseases.

Summary

FLIP Panometry has proven to be a diagnostic tool that can complement, or in some cases be an alternative to, HRM in the evaluation of esophageal dysmotility. The strongest recommended benefit of FLIP in current clinical practice is with clarifying equivocal HRM, such as EGJOO or inconclusive achalasia. There are also promising results demonstrating the role for FLIP in excluding primary motility disorders during an initial endoscopy, as well as for the use of FLIP for evaluating treatment and outcomes in achalasia, gastroesophageal reflux disease (GERD), and eosinophilic esophagitis (EoE). With continued expanding use of FLIP across multiple centers and clinical scenarios, additional evolution of the role for FLIP is anticipated as well.
Literatur
6.
Zurück zum Zitat Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(©). Neurogastroenterol Motil. 2021;33(1):e14058. https://doi.org/10.1111/nmo.14058. Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(©). Neurogastroenterol Motil. 2021;33(1):e14058. https://​doi.​org/​10.​1111/​nmo.​14058.
16.•
Zurück zum Zitat Carlson DA, Baumann AJ, Donnan EN, Krause A, Kou W, Pandolfino JE. Evaluating esophageal motility beyond primary peristalsis: assessing esophagogastric junction opening mechanics and secondary peristalsis in patients with normal manometry. Neurogastroenterol Motil. 2021;33(10):e14116. https://doi.org/10.1111/nmo.14116. Symptomatic patients with normal HRM can have abnormal FLIP Panometry and highlights the role of secondary peristalsis in dysphagia. Carlson DA, Baumann AJ, Donnan EN, Krause A, Kou W, Pandolfino JE. Evaluating esophageal motility beyond primary peristalsis: assessing esophagogastric junction opening mechanics and secondary peristalsis in patients with normal manometry. Neurogastroenterol Motil. 2021;33(10):e14116. https://​doi.​org/​10.​1111/​nmo.​14116. Symptomatic patients with normal HRM can have abnormal FLIP Panometry and highlights the role of secondary peristalsis in dysphagia.
18.•
Zurück zum Zitat Carlson DA, Gyawali CP, Khan A, Yadlapati R, Chen J, Chokshi RV, et al. Classifying esophageal motility by FLIP panometry: a study of 722 subjects with manometry. Am J Gastroenterol. 2021;116(12):2357–66. https://doi.org/10.14309/ajg.0000000000001532. Validated FLIP panometry motility classifications and role in identifying primary esophageal motility disorders. Carlson DA, Gyawali CP, Khan A, Yadlapati R, Chen J, Chokshi RV, et al. Classifying esophageal motility by FLIP panometry: a study of 722 subjects with manometry. Am J Gastroenterol. 2021;116(12):2357–66. https://​doi.​org/​10.​14309/​ajg.​0000000000001532​. Validated FLIP panometry motility classifications and role in identifying primary esophageal motility disorders.
21.•
Zurück zum Zitat Carlson DA, Baumann AJ, Prescott JE, Donnan EN, Yadlapati R, Khan A, et al. Validation of secondary peristalsis classification using FLIP panometry in 741 subjects undergoing manometry. Neurogastroenterol Motil. 2022;34(1):e14192. https://doi.org/10.1111/nmo.14192. Validated FLIP panometry motility classifications and secondary peristalsis in esophageal motility disorders. Carlson DA, Baumann AJ, Prescott JE, Donnan EN, Yadlapati R, Khan A, et al. Validation of secondary peristalsis classification using FLIP panometry in 741 subjects undergoing manometry. Neurogastroenterol Motil. 2022;34(1):e14192. https://​doi.​org/​10.​1111/​nmo.​14192. Validated FLIP panometry motility classifications and secondary peristalsis in esophageal motility disorders.
25.•
Zurück zum Zitat Carlson DA, Schauer JM, Kou W, Kahrilas PJ, Pandolfino JE. Functional lumen imaging probe panometry helps identify clinically relevant esophagogastric junction outflow obstruction per Chicago Classification v4.0. Am J Gastroenterol. 2023;118(1):77–86. https://doi.org/10.14309/ajg.0000000000001980. Use of FLIP to clarify EGJOO on HRM. Carlson DA, Schauer JM, Kou W, Kahrilas PJ, Pandolfino JE. Functional lumen imaging probe panometry helps identify clinically relevant esophagogastric junction outflow obstruction per Chicago Classification v4.0. Am J Gastroenterol. 2023;118(1):77–86. https://​doi.​org/​10.​14309/​ajg.​0000000000001980​. Use of FLIP to clarify EGJOO on HRM.
31.
35.
Zurück zum Zitat Ponds FA, Bredenoord AJ, Kessing BF, Smout AJ. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol Motil. 2017;29(1). https://doi.org/10.1111/nmo.12908. Ponds FA, Bredenoord AJ, Kessing BF, Smout AJ. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol Motil. 2017;29(1). https://​doi.​org/​10.​1111/​nmo.​12908.
36.•
Zurück zum Zitat Carlson DA, Kou W, Rooney KP, Baumann AJ, Donnan E, Triggs JR, et al. Achalasia subtypes can be identified with functional luminal imaging probe (FLIP) panometry using a supervised machine learning process. Neurogastroenterol Motil. 2021;33(3):e13932. https://doi.org/10.1111/nmo.13932. Identifying role of FLIP in clarifying inconclusive achalasia and identifying subtypes. Carlson DA, Kou W, Rooney KP, Baumann AJ, Donnan E, Triggs JR, et al. Achalasia subtypes can be identified with functional luminal imaging probe (FLIP) panometry using a supervised machine learning process. Neurogastroenterol Motil. 2021;33(3):e13932. https://​doi.​org/​10.​1111/​nmo.​13932. Identifying role of FLIP in clarifying inconclusive achalasia and identifying subtypes.
37.•
Zurück zum Zitat Baumann AJ, Donnan EN, Triggs JR, Kou W, Prescott J, Decorrevont A, et al. Normal functional luminal imaging probe panometry findings associate with lack of major esophageal motility disorder on high-resolution manometry. Clin Gastroenterol Hepatol. 2021;19(2):259–68.e1. https://doi.org/10.1016/j.cgh.2020.03.040. Using FLIP Panometry to exclude primary esophageal motility disorders. Baumann AJ, Donnan EN, Triggs JR, Kou W, Prescott J, Decorrevont A, et al. Normal functional luminal imaging probe panometry findings associate with lack of major esophageal motility disorder on high-resolution manometry. Clin Gastroenterol Hepatol. 2021;19(2):259–68.e1. https://​doi.​org/​10.​1016/​j.​cgh.​2020.​03.​040. Using FLIP Panometry to exclude primary esophageal motility disorders.
42.•
Zurück zum Zitat Holmstrom AL, Campagna RAJ, Cirera A, Carlson DA, Pandolfino JE, Teitelbaum EN, et al. Intraoperative use of FLIP is associated with clinical success following POEM for achalasia. Surg Endosc. 2021;35(6):3090–6. https://doi.org/10.1007/s00464-020-07739-6. Use of FLIP panometry in POEM for achalasia. Holmstrom AL, Campagna RAJ, Cirera A, Carlson DA, Pandolfino JE, Teitelbaum EN, et al. Intraoperative use of FLIP is associated with clinical success following POEM for achalasia. Surg Endosc. 2021;35(6):3090–6. https://​doi.​org/​10.​1007/​s00464-020-07739-6. Use of FLIP panometry in POEM for achalasia.
50.
Zurück zum Zitat Carlson DA, Kathpalia P, Craft J, Tye M, Lin Z, Kahrilas PJ, et al. The relationship between esophageal acid exposure and the esophageal response to volumetric distention. Neurogastroenterol Motil. 2018;30(3). https://doi.org/10.1111/nmo.13240. Carlson DA, Kathpalia P, Craft J, Tye M, Lin Z, Kahrilas PJ, et al. The relationship between esophageal acid exposure and the esophageal response to volumetric distention. Neurogastroenterol Motil. 2018;30(3). https://​doi.​org/​10.​1111/​nmo.​13240.
51.
Zurück zum Zitat Tucker E, Sweis R, Anggiansah A, Wong T, Telakis E, Knowles K, et al. Measurement of esophago-gastric junction cross-sectional area and distensibility by an endolumenal functional lumen imaging probe for the diagnosis of gastro-esophageal reflux disease. Neurogastroenterol Motil. 2013;25(11):904–10. https://doi.org/10.1111/nmo.12218.CrossRefPubMed Tucker E, Sweis R, Anggiansah A, Wong T, Telakis E, Knowles K, et al. Measurement of esophago-gastric junction cross-sectional area and distensibility by an endolumenal functional lumen imaging probe for the diagnosis of gastro-esophageal reflux disease. Neurogastroenterol Motil. 2013;25(11):904–10. https://​doi.​org/​10.​1111/​nmo.​12218.CrossRefPubMed
53.•
Zurück zum Zitat Su B, Dunst C, Gould J, Jobe B, Severson P, Newhams K, et al. Experience-based expert consensus on the intra-operative usage of the Endoflip impedance planimetry system. Surg Endosc. 2021;35(6):2731–42. https://doi.org/10.1007/s00464-020-07704-3. Role of FLIP panometry in antireflux surgery. Su B, Dunst C, Gould J, Jobe B, Severson P, Newhams K, et al. Experience-based expert consensus on the intra-operative usage of the Endoflip impedance planimetry system. Surg Endosc. 2021;35(6):2731–42. https://​doi.​org/​10.​1007/​s00464-020-07704-3. Role of FLIP panometry in antireflux surgery.
68.•
69.•
Zurück zum Zitat Carlson DA, Shehata C, Gonsalves N, Hirano I, Peterson S, Prescott J, et al. Esophageal dysmotility is associated with disease severity in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2022;20(8):1719–28.e3. https://doi.org/10.1016/j.cgh.2021.11.002. FLIP panometry clinical application in EoE. Carlson DA, Shehata C, Gonsalves N, Hirano I, Peterson S, Prescott J, et al. Esophageal dysmotility is associated with disease severity in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2022;20(8):1719–28.e3. https://​doi.​org/​10.​1016/​j.​cgh.​2021.​11.​002. FLIP panometry clinical application in EoE.
Metadaten
Titel
FLIP in Clinical Practice: When Is It Helpful?
verfasst von
Elena C. Pezzino, MD
Daniel R. Arndorfer, MD
Dustin A. Carlson, MD, MSCI
Publikationsdatum
27.03.2024
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 2/2024
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-024-00442-8

Weitere Artikel der Ausgabe 2/2024

Current Treatment Options in Gastroenterology 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.